Back to Journals » Therapeutics and Clinical Risk Management » Volume 9

Original Research

Efficacy and safety analysis of once per cycle pegfilgrastim and daily lenograstim in patients with breast cancer receiving adjuvant myelosuppressive chemotherapy FEC 100: a pilot study

       
Total article views   HTML views PDF downloads Totals
9,145 Dovepress* 8,017+ 1,491 9,508
PubMed Central* 1,128 489 1,617
Totals 9,145 1,980 11,125
*Since 11 November 2013
+Since July 2016

View citations on PubMed Central and Google Scholar